Is a science based consulting company. The company has a focus on early clinical drug development. It was formed in 2001 by Dr. Neville Ford following his retirement from the Bristol-Myers Squibb Pharmaceutical Research Institute.
The goal of Woodfield Clinical is to add value to your projects. We have accomplished this in a variety of ways for other clients.
The company has also provided advice to law firms involved with pharmaceutical issues.
However, the primary focus of the company is in the drug development process and particularly in the critical early development phase, where opportunities can be overlooked or unrealistic expectations for a project can lead to a squandering of resources.